Screening of TMA Patients für ADAMTS13 Activity (Adamscreen)
NCT02373267 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2015-02-26
Summary
Screening of TMA patients for ADAMTS13 activity and the description of systemic organ damage and/or organ failure in different entities of thrombotic microangiopathies (TMA)
Conditions
- Thrombotic Microangiopathies
Interventions
- BIOLOGICAL
-
Technozyme
determination of ADAMTS13 activity
Sponsors & Collaborators
-
University of Cologne
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-03-31
- Primary Completion
- 2017-02-28
- Completion
- 2019-02-28
More Related Trials
-
Study of Patients With Thrombotic Microangiopathy Associated With Mitomycin C, Treated or Not With Eculizumab
NCT06098378 ·Status: RECRUITING
-
Improvement of Immunologic and Molecular Techniques for the Diagnosis and Follow-up of Patients With Thrombotic Thrombocytopenic Purpura
NCT05046717 ·Status: ACTIVE_NOT_RECRUITING
-
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
NCT01257269 ·Status: RECRUITING
-
Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia
NCT01668615 ·Status: COMPLETED
-
Retrospective Epidemiological Study of Patients in the National Cohort of the French TMA Center
NCT07205861 ·Status: RECRUITING
-
Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium
NCT04745195 ·Status: RECRUITING
-
Phase 2, Pharmacokinetics Study of Eltrombopag in Japanese Thrombocytopenic Subjects With Chronic Liver Disease
NCT00861601 ·Status: COMPLETED ·Phase: PHASE2
-
Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
NCT03922308 ·Status: COMPLETED ·Phase: PHASE2
-
Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura
NCT01554514 ·Status: COMPLETED ·Phase: PHASE2
-
Drug Etiology of Aplastic Anemia and Related Dyscrasias
NCT00005302 ·Status: COMPLETED
-
Avatrombopag Combined With All-trans Retinoic Acid in the Treatment of Primary Immune Thrombocytopenia
NCT07278908 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITP
NCT06838949 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)
NCT02158936 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy of a Personalized Caplacizumab Regimen Based on ADAMTS13 Activity Monitoring in Adult aTTP
NCT04720261 ·Status: TERMINATED ·Phase: PHASE2
-
International Registry and Biorepository for TMA(Thrombotic Microangiopathy)
NCT00593229 ·Status: TERMINATED
-
Efficacy and Safety of Avatrombopag Combined With IST for the Treatment of HAAA and SAA With Abnormal Liver Function
NCT05571332 ·Status: UNKNOWN ·Phase: NA
-
Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura
NCT06137105 ·Status: NOT_YET_RECRUITING
-
Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment
NCT05382013 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
NCT00828750 ·Status: COMPLETED ·Phase: PHASE3
-
Antithrombin-III for Patients With Hepatic Veno-occlusive Diseases Following Hematopoietic Stem Cell Transplantation
NCT01886248 ·Status: UNKNOWN ·Phase: PHASE2
-
.German TTP-Registry (Thrombotic Thrombocytopenic Purpura)
NCT05389007 ·Status: UNKNOWN
-
Immune Thrombocytopenia Management in Adults
NCT05861297 ·Status: UNKNOWN ·Phase: PHASE4
-
Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia
NCT06281327 ·Status: RECRUITING ·Phase: PHASE2
-
Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant
NCT04543591 ·Status: COMPLETED ·Phase: PHASE3
-
N-Acetylcysteine as Therapy for Transplantation- Associated Thrombotic Microangiopathy
NCT07279610 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3